Mark Pruzanski, President & CEO at INTERCEPT PHARMACEUTICALS, INC. (ICPT), sold 417 shares at $125.00 ($52K) on 2019-12-26, disclosed to the SEC on 2019-12-30.
Open-market sale of $52k ICPT by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ICPT | SELL | 2018-11-16 | $9.1M | — | Filing → |
| ICPT | BUY | 2018-04-09 | $500K | — | Filing → |
| ICPT | SELL | 2017-10-04 | $180K | — | Filing → |